Drug
Probuphine (buprenorphine implant)
Probuphine (buprenorphine implant) is a pharmaceutical drug with 5 clinical trials. Historical success rate of 60.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
60.0%
Based on 3 completed trials
Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(40%)
Phase Distribution
Ph phase_3
5
100%
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
5(100.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
60.0%
Most Advanced
Phase 3
Trials by Phase
Phase 35 (100.0%)
Trials by Status
terminated240%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
terminatedphase_3
Study of Probuphine in Patients With Opioid Dependence
NCT00772785
completedphase_3
Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
NCT00630201
completedphase_3
Re-Treatment Study of Probuphine in Opioid Addiction
NCT01262261
completedphase_3
A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction
NCT01114308
terminatedphase_3
A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence
NCT00768482
Clinical Trials (5)
Showing 5 of 5 trials
NCT00772785Phase 3
Study of Probuphine in Patients With Opioid Dependence
NCT00630201Phase 3
Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
NCT01262261Phase 3
Re-Treatment Study of Probuphine in Opioid Addiction
NCT01114308Phase 3
A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction
NCT00768482Phase 3
A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5